The FDA issued warning letters to 30 telehealth companies over misleading claims about compounded versions of popular ...
Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...
A new survey suggests about three million Canadian adults are currently taking GLP-1 drugs such as Ozempic or Mounjaro and ...
Thinking about GLP-1 meds? A Hy-Vee dietitian explains how to eat to protect muscle, energy and digestion when your appetite ...
Consumer health advertising is driving many employees to take action on GLP-1s. But without guidance, those decisions could ...
Social media influencers and supplement companies have stoked concerns, but experts say the issue is a lot more complicated.
GLP-1s are changing the menu landscape for restaurants as diners fundamentally change how they eat. Here's what you'll start ...
GLP-1 weight loss drugs have quickly moved from medical journals to household conversations, reshaping how Americans think ...
Combining GLP-1 medications with 8 healthy lifestyle habits reduced the risk of major adverse cardiovascular events, or MACE, ...
“GLP‑1s have effectively created a third pillar of pharmacy spend and most employers don't yet have a mature playbook to ...
GLP-1 receptor agonists hold key market opportunities due to their effectiveness in diabetes and obesity management, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results